Literature DB >> 23026234

Detection of antinuclear antibodies by automated indirect immunofluorescence analysis.

Xavier Bossuyt1, Sarah Cooreman, Heidi De Baere, Patrick Verschueren, René Westhovens, Daniel Blockmans, Godelieve Mariën.   

Abstract

BACKGROUND: Testing for antinuclear antibodies is useful for the diagnosis of systemic rheumatic diseases. Automated systems for image acquisition and interpretation of indirect immunofluorescence-based tests are increasingly used. The diagnostic performance of such automated approach in untreated patients has not been reported.
METHODS: Antinuclear antibodies were measured by automated indirect immunofluorescence using Zenit G. Sight on HEp2 and HEp2000 substrate in 268 consecutive samples submitted to the laboratory for antinuclear antibody testing, and in 231 patients with a systemic rheumatic disease at the time of diagnosis, 143 blood donors, 134 patients with chronic fatigue syndrome, and 133 diseased controls.
RESULTS: Image acquisition by G-Sight was of high quality. The accuracy of pattern assignment was limited. There was a significant correlation between automated estimation of fluorescence intensity (probability index of positivity) and end-point titer. Probability index interval specific likelihood ratios for systemic rheumatic disease increased with increasing level of positivity probability. With the HEp-2 substrate, the likelihood ratio for systemic lupus erythematosus was 0.06, 0.4, 6.8, 12.1, and 43.9 for a probability measure of positivity of ≤10, 11-≤30, 31-≤50, 51-≤85, and >85, respectively.
CONCLUSION: Quantitative data generated by automated image acquisition facilitates standardized interpretation.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23026234     DOI: 10.1016/j.cca.2012.09.021

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  17 in total

1.  Clinical performance evaluation of a novel, automated chemiluminescent immunoassay, QUANTA Flash CTD Screen Plus.

Authors:  Chelsea Bentow; Gabriella Lakos; Rachel Rosenblum; Cassandra Bryant; Andrea Seaman; Michael Mahler
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  The burden of the variability introduced by the HEp-2 assay kit and the CAD system in ANA indirect immunofluorescence test.

Authors:  M Infantino; F Meacci; V Grossi; M Manfredi; M Benucci; M Merone; P Soda
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

3.  A fluorometric clenbuterol immunoassay using sulfur and nitrogen doped carbon quantum dots.

Authors:  Dongmei Yao; Aihui Liang; Zhiliang Jiang
Journal:  Mikrochim Acta       Date:  2019-05-02       Impact factor: 5.833

4.  Original approach for automated quantification of antinuclear autoantibodies by indirect immunofluorescence.

Authors:  Daniel Bertin; Noémie Jourde-Chiche; Pierre Bongrand; Nathalie Bardin
Journal:  Clin Dev Immunol       Date:  2013-12-18

Review 5.  Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

Authors:  Michael Mahler; Pier-Luigi Meroni; Xavier Bossuyt; Marvin J Fritzler
Journal:  J Immunol Res       Date:  2014-04-27       Impact factor: 4.818

6.  Serum autoantibodies: from identification to clinical relevance.

Authors:  Pietro Invernizzi; Xavier Bossuyt; Dimitrios P Bogdanos
Journal:  Clin Dev Immunol       Date:  2013-03-20

7.  Interpretation of ANA indirect immunofluorescence test outside the darkroom using NOVA view compared to manual microscopy.

Authors:  Susan S Copple; Troy D Jaskowski; Rashelle Giles; Harry R Hill
Journal:  J Immunol Res       Date:  2014-02-24       Impact factor: 4.818

Review 8.  Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations.

Authors:  Pier Luigi Meroni; Nicola Bizzaro; Ilaria Cavazzana; Maria Orietta Borghi; Angela Tincani
Journal:  BMC Med       Date:  2014-03-03       Impact factor: 8.775

9.  The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated system.

Authors:  Francesca Buzzulini; Amelia Rigon; Paolo Soda; Leonardo Onofri; Maria Infantino; Luisa Arcarese; Giulio Iannello; Antonella Afeltra
Journal:  Arthritis Res Ther       Date:  2014-03-14       Impact factor: 5.156

10.  Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.

Authors:  Mandy Sowa; Kai Grossmann; Ilka Knütter; Rico Hiemann; Nadja Röber; Ursula Anderer; Elena Csernok; Dimitrios P Bogdanos; Maria Orietta Borghi; Pier Luigi Meroni; Peter Schierack; Dirk Reinhold; Karsten Conrad; Dirk Roggenbuck
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.